NCT02095886View on ClinicalTrials.gov

Relative Bioavailability Study With BMS-955176

PHASE1CompletedINTERVENTIONAL

Enrollment

47

Participants

Timeline

Start Date

March 25, 2014

Primary Completion Date

July 7, 2014

Study Completion Date

July 7, 2014

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG

BMS-955176

BMS-955176

Trial Locations (1)

NG11 6JS

GSK Investigational Site, Nottingham

Sponsors

Lead Sponsor

ViiV Healthcare

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY